The antiepileptic drug topiramate has also proven effective in preventing migraines. A study published in the scientific journal "Neurology" describes how taking topiramate during pregnancy can increase the risk of birth defects in newborns. The study clarifies that pregnant women must expect an increased risk of birth defects in their children if they have taken topiramate.
Birth defects are a known risk when using antiepileptic drugs. Therefore, this study does not present any surprising new findings. However, it does confirm that women who may become pregnant should be closely monitored regarding the course of their migraines, as well as the tolerability and effectiveness of preventive measures. Migraine patients planning a pregnancy should always inform their doctor so that appropriate considerations can be taken into account when planning migraine prophylaxis.
Leave a comment